Open AccessEvaluation and Management of Mallory – Weiss Syndrome: A Review
Author(s) -
Mohammed Salah Hussein,
Fatimah Ali Alfaraj,
Abdulrahman Dhafer Alshabwi,
Aljawhara Abdullah Altheyab,
Khulood Tariq Alhasan,
Omar Mohammed Alghamdi,
Manal Abdulla Jaafar Saleh Ahmed,
Amal Ali Alamri,
Mohammed Tariq Alhabeeb,
Abdelhalim A. Elsherif,
Lojain Saoud Zaki
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60a34548
Subject(s) - mallory–weiss syndrome , melena , medicine , upper gastrointestinal bleeding , etiology , asymptomatic , gastroesophageal junction , endoscopy , surgery , endoscopic treatment , tears , disease , general surgery , adenocarcinoma , cancer
Upper gastrointestinal bleeding is a symptom of Mallory-Weiss syndrome, which is caused by longitudinal mucosal lacerations (known as Mallory-Weiss tears) near the gastroesophageal junction or gastric cardia. Mallory-Weiss syndrome is rather prevalent, accounting for 3 to 10% of all upper gastrointestinal bleeding episodes. In mild circumstances, the disease may be asymptomatic. Hematemesis is the presenting symptom in 85 percent of patients. Blood is present in varying amounts, ranging from blood-streaked mucous to huge bright red haemorrhage. Other symptoms such as melena, dizziness, or syncope might occur as a result of heavy bleeding. The majority of the time, the bleeding is little and ends on its own. Endoscopy is frequently used to confirm the diagnosis of MWS. Although most patients may be treated with monitoring or conservative medicinal treatment, certain cases require endoscopic or surgical treatment. Despite the fact that MWS is a common cause of nonvariceal upper gastrointestinal bleeding (NVUGIB), little research has been done on it. This article discusses MWS Etiology, epidemiology, evaluation and management.